Inefficient skeletal muscle oxidative function flanks impaired motor neuron recruitment in Amyotrophic Lateral Sclerosis during exercise

F Lanfranconi, A Ferri, G Corna, R Bonazzi, C Lunetta, V Silani, N Riva, A Rigamonti, A Maggiani, C Ferrarese, L Tremolizzo, F Lanfranconi, A Ferri, G Corna, R Bonazzi, C Lunetta, V Silani, N Riva, A Rigamonti, A Maggiani, C Ferrarese, L Tremolizzo

Abstract

This study aimed to evaluate muscle oxidative function during exercise in amyotrophic lateral sclerosis patients (pALS) with non-invasive methods in order to assess if determinants of reduced exercise tolerance might match ALS clinical heterogeneity. 17 pALS, who were followed for 4 months, were compared with 13 healthy controls (CTRL). Exercise tolerance was assessed by an incremental exercise test on cycle ergometer measuring peak O2 uptake ([Formula: see text]O2peak), vastus lateralis oxidative function by near infrared spectroscopy (NIRS) and breathing pattern ([Formula: see text]E peak). pALS displayed: (1) 44% lower [Formula: see text]O2peak vs. CTRL (p < 0.0001), paralleled by a 43% decreased peak skeletal muscle oxidative function (p < 0.01), with a linear regression between these two variables (r2 = 0.64, p < 0.0001); (2) 46% reduced [Formula: see text]Epeak vs. CTRL (p < 0.0001), achieved by using an inefficient breathing pattern (increasing respiratory frequency) from the onset until the end of exercise. Inefficient skeletal muscle O2 function, when flanking the impaired motor units recruitment, is a major determinant of pALS clinical heterogeneity and working capacity exercise tolerance. CPET and NIRS are useful tools for detecting early stages of oxidative deficiency in skeletal muscles, disclosing individual impairments in the O2 transport and utilization chain.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1
Figure 1
Correlation between exercise tolerance (V˙O2peak) and vastus lateralis O2 extraction at peak of exercise (Δ[HHb]/Δ[HHb]isch), in pALS (black line) and CTRL (broken line, not significant). White circles: pALS at baseline (T0); white squares: pALS after 4 months (T1); grey triangles: matched healthy CTRL.
Figure 2
Figure 2
Correlation between peak blood lactate concentration [La] and peak power at exhaustion, normalized for metabolic mass (fatty free mass, FFM), in pALS and CTRL. Four quadrants were defined by drawing dotted lines, according to one SD below the average for CTRL for both variables. White circles: pALS at baseline (T0); white squares: pALS after 4 months (T1); grey triangles: matched healthy CTRL; grey dot: pALS with vastus lateralis O2 extraction >35%. Black arrow indicates 1 patient with atypical behavior.
Figure 3
Figure 3
Panel (A) Correlation between V˙O2 values at exhaustion and clinical scores of ALS disease (ALSFRS-R questionnaire), recorded at baseline (T0) and after 4 months (T1). Patients with ALSFRS-R score lower than 39 (dotted line) had shorter survival time. The broken line is related only to pALS bulb. Panel (B) Correlation between V˙O2 peak and the change in ALSFRS_R score after 4 months (T1–T0). Patients with ALSFRS-R score higher than 0.65 (dotted line) had shorter survival time. Panel (C) Correlation between Mini Nutritional Assessment (MNA) questionnaire scores and ALSFRS-R at T0. Patients with 16.5 < MNA < 25 had a risk of malnutrition, while patients with MNA < 16.5 were malnourished. White circles: pALS at T0; white squares: pALS at T1; black triangles: pASL with bulbar onset (pALS bulb).
Figure 4
Figure 4
Relationships between V˙O2 and ventilation (V˙E) values during exercise in representative participants from the pALS (black squares) and CTRL (crosses) groups. Individually, iso-respiratory frequency (Rf) lines are indicated (pALS, continuous lines; CTRL, broken lines).
Figure 5
Figure 5
Correlation between orthostatic lung vital capacity (FVC) and vastus lateralis O2 extraction (Δ[HHb]/Δ[HHb]isch) at exhaustion, at baseline (T0) and after 4 months (T1), in pALS. White circles: pALS at T0; white squares: pALS at T1. Black arrow indicates 1 pALS with bulbar onset who was incapable of performing fully and correctly the spirometry maneuver.

References

    1. Mezzani A, et al. Reduced exercise capacity in early-stage amyotrophic lateral sclerosis: Role of skeletal muscle. Amyotroph Lateral Scler. 2012;13:87–94. doi: 10.3109/17482968.2011.601463.
    1. Simon NG, et al. Quantifying disease progression in amyotrophic lateral sclerosis. Ann Neurol. 2014;76:643–657. doi: 10.1002/ana.24273.
    1. Sharma KR, et al. Physiology of fatigue in amyotrofic lateral sclerosis. Neurology. 1995;45:733–740. doi: 10.1212/WNL.45.4.733.
    1. Dal Bello-Haas V, Florence JM. Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease. Cochrane Database Syst Rev. 2013;5:CD005229.
    1. Echantez-Laguna A, et al. Mitochondrial respiratory chain function in skeletal muscle of ALS patients. Ann Neurol. 2002;52:623–627. doi: 10.1002/ana.10357.
    1. Aboussouan LS. Mechanism of exercise limitation and pulmonary rehabilitation for patients with neuromuscular disease. Chronic Resp Dis. 2009;6:231–249. doi: 10.1177/1479972309345927.
    1. Finsterer J. Lactate stress testing in sporadic amyotrophic lateral sclerosis. Int J Neurosci. 2005;115:583–591. doi: 10.1080/00207450590522847.
    1. Siciliano G, et al. Impaired oxidative metabolism in exercising muscle from ALS patients. J Neurol Sci. 2009;191:61–65. doi: 10.1016/S0022-510X(01)00620-7.
    1. Lanfranconi F, et al. Near infrared spectroscopy (NIRS) as a new non-invasive tool to detect oxidative skeletal muscle impairment in children survived to acute lymphoblastic leukaemia. PLoS One. 2014;9:e99282. doi: 10.1371/journal.pone.0099282.
    1. Lanfranconi F, et al. Noninvasive evaluation of skeletal muscle oxidative metabolism after heart transplant. Med Sci Sports Exerc. 2006;38:1374–1383. doi: 10.1249/01.mss.0000228943.62776.69.
    1. Ferrari M, Mottola L, Quaresima V. Principles, technique and limitations of near infrared spectroscopy. Can J Appl Physiol. 2004;29:463–487. doi: 10.1139/h04-031.
    1. Grassi B, Quaresima V. Near-infrared spectroscopy and skeletal muscle oxidative function in vivo in health and disease: a review from an exercise physiology perspective. J Biomed Opt. 2016;21:091313. doi: 10.1117/1.JBO.21.9.091313.
    1. Ryan TE, et al. Skeletal muscle oxidative capacity in amyotrophic lateral sclerosis. Muscle Nerve. 2014;50:767–774. doi: 10.1002/mus.24223.
    1. Nichols NL, et al. Ventilatory control in ALS. Respir Physiol Neurobiol. 2013;189:429–437. doi: 10.1016/j.resp.2013.05.016.
    1. Cedarbaum JM, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III) J Neurol Sci. 1999;169:13–12. doi: 10.1016/S0022-510X(99)00210-5.
    1. Kollewe K, et al. ALSFRS-R score and its ratio: a useful predictor for ALS-progression. J Neurol Sci. 2008;275:69–73. doi: 10.1016/j.jns.2008.07.016.
    1. Vellas B, et al. The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition. 1999;15:116–122. doi: 10.1016/S0899-9007(98)00171-3.
    1. Jackson AS, Pollock ML. Generalized equations for predicting body density of men. Br J Nutr. 1978;40:497–504. doi: 10.1079/BJN19780152.
    1. Jackson AS, Pollock ML, Ward A. Generalized equations for predicting body density of women. Med Sci Sports Exerc. 1980;12:175–181.
    1. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14:377–381.
    1. Grassi B, et al. Impaired oxygen extraction in metabolic myopathies: detection and quantification by near-infrared spectroscopy. Muscle Nerve. 2007;35:510–520. doi: 10.1002/mus.20708.
    1. Al Sarraj S, et al. Mitochondrial abnormalities and low grade inflammation are present in the skeletal muscle of a minority of patients with amyotrophic lateral sclerosis; an observational myopathology study. Acta Neuropathol Commun. 2014;2:165. doi: 10.1186/s40478-014-0165-z.
    1. Taivassalo T, et al. The spectrum of exercise tolerance in mitochondrial myopathies: a study of 40 patients. Brain. 2003;126:413–423. doi: 10.1093/brain/awg028.
    1. Brockington A, et al. Unravelling the enigma of selective vulnerability in neurodegeneration: motor neurons resistant to degeneration in ALS show distinct gene expression characteristics and decreased susceptibility to excitotoxicity. Acta Neuropathol. 2013;125:95–109. doi: 10.1007/s00401-012-1058-5.
    1. Ngo ST, Stein FJ, McCombe PA. Body mass index and dietary intervention: implications for prognosis of amyotrophic lateral sclerosis. J Neurol Sci. 2014;340:5–12. doi: 10.1016/j.jns.2014.02.035.

Source: PubMed

3
Abonner